Multicentre Canadian Study to Measure the Safety and Efficacy of Radiosynoviorthesis
Summary
Radiation synovectomy by intra-articular injection of beta-emitting radionuclides is considered a reliable and easy-to-perform therapy without harmful side-effects for the treatment of inflammatory joint disease in many countries. The goal of this study is to demonstrate Yttrium-90 citrate colloid or Rhenium-186 sulfide synovectomy are appropriate therapeutic interventions in patients with persistent active synovitis of a joint (characterized by pain, tenderness, and effusion) which is resistant to systemic therapy and intra-articular corticosteroid injections. The primary objective will be to assess the safety of an intra-articular administration of Yttrium-90 citrate colloid or Rhenium-186 sulfide. The secondary objective will be to assess the efficacy on synovitis.
Timeline
- Start
- 2012-05-31
- Primary completion
- 2017-12-31
- Completion
- 2018-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rhenium-186 sulfide | Unknown | — | Other |
| Subject | Yttrium-90 citrate colloid | Unknown | 111 mbq | Other |
| Subject | Yttrium-90 citrate colloid | Unknown | 222 mbq | Other |